A Look at Capricor Therapeutics Inc (CAPR) Shares in the Recent Past Indicates Growth

With 1.13 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.19 million shares. The 52-week range on CAPR shows that it touched its highest point at $23.40 and its lowest point at $3.52 during that stretch. It currently has a 1-year price target of $41.29. Beta for the stock currently stands at 4.11.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CAPR was up-trending over the past week, with a rise of 11.94%, but this was up by 10.15% over a month. Three-month performance dropped to -18.39% while six-month performance rose 281.06%. The stock gained 300.27% in the past year, while it has gained 9.35% so far this year. A look at the trailing 12-month EPS for CAPR yields -1.06 with Next year EPS estimates of -0.98. For the next quarter, that number is -0.17. This implies an EPS growth rate of -43.37% for this year and 17.41% for next year.

Float and Shares Shorts:

At present, 40.33 million CAPR shares are outstanding with a float of 39.97 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CAPR since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.63926 being high and -$1.34736 being low. For CAPR, this leads to a yearly average estimate of -$1.19. Based on analyst estimates, the high estimate for the next quarter is -$0.3 and the low estimate is -$0.4. The average estimate for the next quarter is thus -$0.35.